前五大供应商集中

港股IPO招股书披露先例 · 412 家公司,412 项

此类事项指招股书披露申请人向前五大供应商采购占总采购的比例达到重大水平。相关披露通常见于概要、风险因素、业务及财务资料章节,一般载明往绩记录期间各年采购金额及占比、最大供应商占比和供应商类型,并解释供应商遴选与管理机制、多元采购或长期框架协议等安排,以及前五大供应商均为独立第三方、董事及主要股东概无于其中拥有权益。

2025-06-13Prospectus
佰泽医疗集团Bayzed Health Group Inc02609.HK

前五大供应商采购占比升至46.6%

For each year during the Track Record Period, purchases from our five largest suppliers collectively accounted for 34.4%, 39.0% and 46.6% of our total purchases, respectively, and for each year during the Track Record Period, purchases from our largest supplier accounted for 12.6%, 16.3% and 15.3% of our total purchases, respectively.

Summary · 第 14 页

To obtain favorable and stable purchase prices, we actively strengthen the communication with our suppliers, increase the purchase volume, so as to establish and maintain long-term and stable cooperative relations with those suppliers.

Financial Information · 第 549 页

As of the Latest Practicable Date, all of our five largest suppliers in each year during the Track Record Period were Independent Third Parties, and to the best of the knowledge of our Directors, none of our Directors, their respective associates or any shareholder who owned more than 5% of our issued share capital had any interest in any of our five largest suppliers in each year during the Track Record Period.

Business · 第 387 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2025-06-13Prospectus
药捷安康(南京)科技股份有限公司TransThera Sciences (Nanjing), Inc.02617.HK

五大供应商采购占比最高达60.9%

For the years ended December 31, 2023 and 2024, our purchases from our five largest suppliers in each year/period during the Track Record Period in aggregate accounted for 48.4% and 60.9% of our total purchases for the respective year, respectively, and our purchases from our largest supplier in each year during the Track Record Period alone accounted for 19.0% and 37.6% of our total purchases for the respective year, respectively.

Business · 第 394 页

In addition, we believe that adequate alternative sources for such supplies exist and we have developed alternative sourcing strategies for these supplies.

Business · 第 394 页

Other than the agreements with certain CROs, CMO or CDMOs, we order supplies and services on a purchase order basis and do not enter into long-term dedicated capacity or minimum supply arrangements.

Business · 第 394 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2025-05-30Prospectus
容大合众(厦门)科技集团股份公司Rongta Technology (Xiamen) Group Co., Ltd.09881.HK

前五大供应商采购占销售成本逾两成

The total purchase of our top five suppliers in each year amounted to approximately RMB79.3 million, RMB70.4 million and RMB55.9 million for FY2022, FY2023 and FY2024, respectively, representing approximately 26.1%, 26.7% and 22.3% of our total cost of sales during the same period.

Business · 第 244 页

We have developed stable relationships with our top five suppliers for the Track Record Period ranging from four to seven years.

Business · 第 244 页

We do not rely on any of our current suppliers as there are viable substitutes available on the market to meet our needs at a comparable price and quality.

Business · 第 248 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2025-05-22Prospectus
手回集团有限公司Shouhui Group Limited02621.HK

前五大供应商采购占比27.4%至33.1%

During the Track Record Period, purchases from our top five suppliers in each year amounted to RMB174.3 million, RMB216.3 million and RMB234.8 million, respectively, accounting for 33.1%, 20.0% and 27.4% of our total purchases in the respective year.

Summary · 第 7 页

We proactively take preventive measures including regularly monitoring the activities of promotional service providers and reviewing articles prepared by promotional service providers before the articles are posted.

Summary · 第 7 页

During the Track Record Period and up to the Latest Practicable Date, we had not experienced any significant fluctuation in prices set by our suppliers, material breach of contract on the part of our suppliers, or delay in delivery from our suppliers.

Business · 第 292 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2025-05-19Prospectus
厦门吉宏科技股份有限公司Xiamen Jihong Co., Ltd02603.HK

前五大供应商采购占比及跨境电商供应商集中

For each year of the Track Record Period, purchases from our five largest suppliers accounted for 34.6%, 39.6% and 38.1% of our total purchases, and purchases from our largest supplier accounted for 14.5%, 14.5% and 13.8% of our total purchases.

Summary · 第 8 页

For each year of the Track Record Period, the purchases from our five largest suppliers for our cross-border social e-commerce business accounted for 49.5%, 54.6% and 55.7% of our total purchases of our cross-border social e-commerce business.

Summary · 第 8 页

During the Track Record Period, our top five suppliers were primarily digital marketing service providers.

Business · 第 263 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2025-05-19Prospectus

往绩期间五大供应商采购占比66.3%及47.5%

In 2023 and 2024, our purchases from our five largest suppliers in each period in aggregate amounted to RMB137.1 million and RMB32.6 million, respectively, representing 66.3% and 47.5% of our total corresponding purchases in such periods, respectively, and our purchases from the largest supplier in each period accounted for 33.0% and 16.0% of our total corresponding purchases, respectively.

Business · 第 370 页

We do not rely on any of such suppliers as we believe that adequate alternative sources for such supplies of relevant services/raw materials (such as active pharmaceutical ingredient of our drug candidates) exist, and we have developed alternative sourcing strategies for these supplies.

Business · 第 369 页

Our material increase in the expenses attributable to the five largest suppliers during the Track Record Period is in line with the advancement of clinical trials of our Core Product.

Business · 第 370 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2025-05-15Prospectus
江苏恒瑞医药股份有限公司Jiangsu Hengrui Pharmaceuticals Co., Ltd.01276.HK

前五大原材料供应商占销售成本24%至28%

In each of the years ended December 31, 2022, 2023 and 2024, our aggregate purchases from our five largest raw material suppliers amounted to RMB842.5 million, RMB957.1 million, and RMB948.0 million, respectively, representing 24.1%, 27.0%, and 28.0% of our cost of sales for these respective periods.

Business · 第 322 页

We generally contract with more than one supplier for each major type of raw material, except for very few specified raw materials for which we contract with exclusive suppliers.

Business · 第 314 页

During the Track Record Period, the major APIs we procured were irbesartan, valsartan, imrecoxib, paclitaxel, capecitabine and febuxostat, and the purchase prices of these major APIs did not experience any material unfavorable fluctuations.

Business · 第 313 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2025-05-15Prospectus

前五大供应商采购占比波动大

For each period during the Track Record Period, our purchase from our five largest suppliers amounted to US$14.9 million, US$3.7 million and US$6.2 million, respectively, accounting for 48.4%, 28.4% and 56.2% of our total purchases, respectively.

Business · 第 418 页

Specifically, we have identified two to five alternative suppliers in the market and may engage them to ensure a stable and sufficient supply for the production of our products and product candidates once approved.

Business · 第 422 页

As of the Latest Practicable Date, some of our key raw materials including enzymes, plastic tubes and primers were imported from three suppliers located outside Singapore.

Business · 第 424 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2025-05-12Prospectus
宁德时代新能源科技股份有限公司Contemporary Amperex Technology Co., Limited03750.HK

往绩期间五大供应商采购占比16.3%至21.3%

During the Track Record Period, our purchases from the five largest suppliers in each year accounted for 21.3%, 20.3% and 16.3% of our total purchases in the respective year; and purchases from our largest supplier in each year accounted for 5.4%, 5.3% and 6.0% of our total purchases in the respective year.

Summary · 第 6 页

During the Track Record Period, we maintained stable business relationships with our five largest suppliers in each year.

Business · 第 199 页

We shortlisted a panel of suppliers and have established long-term stable partnerships with key suppliers.

Business · 第 201 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2025-04-28Prospectus
海南钧达新能源科技股份有限公司Hainan Drinda New Energy Technology Co., Ltd.02865.HK

前五大供应商采购占比47.2%、34.4%及56.2%

In 2022, 2023 and 2024, purchase from each of the top five suppliers of the continuing operation amounted to RMB5,574.4 million, RMB8,608.1 million and RMB4,915.1 million, accounting for 47.2%, 34.4% and 56.2% of our total purchase for the corresponding years, respectively.

Business · 第 266 页

According to Frost & Sullivan, the top ten silicon wafer manufacturers globally accounted for 89.4% of the world's production in 2022.

Business · 第 267 页

In addition, during the Track Record Period, we successfully managed dependency on any single supplier by cooperating with more major players in the PV industry, which is evidenced by the changing composition of our top five suppliers of our continuing operation.

Business · 第 267 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2025-04-25Prospectus
博雷顿科技股份公司Breton Technology Co., Ltd.01333.HK

前五大供应商采购占比最高达68.5%

In 2022, 2023 and 2024, the aggregate purchases attributable to our five largest suppliers for each year of the Track Record Period amounted to RMB336.7 million, RMB318.7 million and RMB347.4 million, respectively, representing 68.5%, 66.3% and 56.7% of our total purchases for the corresponding years.

Summary · 第 13 页

Purchases attributable to our single largest supplier amounted to RMB174.1 million, RMB189.0 million and RMB153 million for the same years, accounting for 35.4%, 39.4% and 24.9% of our total purchases for the corresponding years.

Business · 第 260 页

In addition to maintaining strong ties with our major suppliers, we are proactively expanding our supplier network to broaden our sourcing channels for key components, thereby reducing dependency on our existing suppliers and enhancing our supply chain resilience.

Business · 第 227 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2025-04-07Prospectus
映恩生物Duality Biotherapeutics, Inc.09606.HK

前五大供应商采购占比升至67.1%

For the years ended December 31, 2023 and 2024, our purchases from our five largest suppliers in each year in aggregate accounted for 42.0% and 67.1% of our total purchases for the respective year, respectively.

Business · 第 423 页

Our purchases from our largest supplier in each year accounted for 12.5% and 25.7% of our total purchases for the respective year, respectively.

Business · 第 423 页

We have maintained stable business relationships with our major suppliers.

Business · 第 423 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2025-04-03Prospectus
江苏正力新能电池技术股份有限公司Jiangsu Zenergy Battery Technologies Group Co., Ltd.03677.HK

前五大供应商采购占比最高达66.1%

In 2021, 2022, 2023 and 2024, purchases from our largest supplier in each year during the Track Record Period amounted to RMB665.0 million, RMB1,326.6 million, RMB433.9 million and RMB674.8 million, representing 40.8%, 38.2%, 14.3% and 19.1% of our total amount of purchase during the respective years, while purchases from our five largest suppliers in each year during the Track Record Period amounted to RMB1,079.3 million, RMB2,230.0 million, RMB1,368.1 million and RMB1,736.4 million, representing 66.1%, 64.2%, 45.0% and 49.2% of our total amount of purchase during the respective years.

Business · 第 294 页

Unless specifically otherwise required by our customers, we maintain alternative suppliers for all of our key raw materials.

Business · 第 287 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2025-03-19Prospectus
舒宝国际集团有限公司Soft International Group Ltd02569.HK

前五大供应商占采购成本约三成半至四成半

5 Supplier E See Note 5. | Polypropylene | 2021 | Prepayment Bank transfer | 7,141 3.6 89,275 45.1

Business · 第 209 页

To reduce the risk of price fluctuation, and as one of our internal control measures to ensure a stable supply of raw materials that satisfy our quality requirements, we have approximately three alternative suppliers within the PRC for each type of our key raw materials.

Business · 第 208 页

To maintain strong relationships with our key suppliers, some of whom are dominant players in the market, we typically place orders on a regular basis, regardless of periodic fluctuations in our operations.

Financial Information · 第 276 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2025-03-17Prospectus
南山铝业国际控股有限公司Nanshan Aluminium International Holdings Limited02610.HK

前五大供应商采购占比近八成至近半

Our five largest suppliers together accounted for 79.4%, 68.9%, 53.7% and 47.0%, respectively, of our total procurement in each year/period of the Track Record Period. Supplier A was our largest supplier in each year/period of the Track Record Period, accounting for 30.8%, 26.9%, 15.7% and 14.3% of our total procurement amount during the same periods.

Business · 第 207 页

In supplier selection, we primarily consider factors such as the price, the quality of the raw materials, the timing of the delivery, payment method, candidate's credit history, and feedback received from our production department.

Business · 第 207 页

Our Directors consider that we do not have material reliance on Mr. Santony, Mr. George Santos and/or his associates as our Group can find substitute suppliers for bauxite in Indonesia with the abundant supply of good quality bauxite locally.

Business · 第 216 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2025-03-13Prospectus
维升药业VISEN Pharmaceuticals02561.HK

前五大供应商采购占比达45%至54%

Purchases from our five largest suppliers, for 2022, 2023 and the nine months ended September 30, 2024 were RMB87.4 million, RMB30.0 million and RMB22.4 million, respectively, representing 53%, 45% and 54% of our total purchase cost for the respective period.

Business · 第 354 页

Save for Ascendis Pharma, all of our five largest suppliers during the Track Record Period are Independent Third Parties, and none of our Directors, their respective associates nor any Shareholder who, to the knowledge of our Directors, owned more than 5% of our issued share capital as at the Latest Practicable Date, has any interest in any of our five largest suppliers during the Track Record Period.

Business · 第 354 页

In addition, we believe that adequate alternative sources for such supplies exist and we have developed alternative sourcing strategies for these supplies.

Business · 第 355 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2024-12-31Prospectus
布鲁可集团有限公司Bloks Group Limited00325.HK

前五大供应商采购占比最高达90.5%

In 2021, 2022 and 2023 and the six months ended June 30, 2024, purchases from our five largest suppliers in each year or period during the Track Record Period accounted for 82.3%, 82.2%, 90.5% and 71.6% of our total purchases for such year or period during the Track Record Period.

Summary · 第 11 页

Purchases from our partner factories accounted for the majority of our purchases during the Track Record Period.

Business · 第 219 页

As we possess the key know-how and patents, we can work with new factories and set up the production lines within approximately three months.

Business · 第 199 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2024-12-18Prospectus
讯飞医疗科技股份有限公司Xunfei Healthcare Technology Co., Ltd.02506.HK

前五大供应商采购占比约四成且最大供应商占比达27.9%

In 2021, 2022, 2023 and the six months ended June 30, 2024, purchases from our five largest suppliers in each year/period accounted for 40.8%, 42.2%, 40.1% and 38.8% of our total purchases, respectively.

Summary · 第 7 页

During the same periods, our single largest supplier in each year/period contributed 27.9%, 21.8%, 18.1% and 20.2% of our total purchases, respectively.

Business · 第 306 页

We believe that we would be able to find alternative suppliers if required, given the relatively homogeneous nature of our supplies, procurement capabilities and relatively large supplier base in the market.

Business · 第 277 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2024-12-18Prospectus
英诺赛科(苏州)科技股份有限公司InnoScience (Suzhou) Technology Holding Co., Ltd.02577.HK

前五大供应商采购占比最高达55.6%

Purchases from each of our largest supplier for the years ended December 31, 2021, 2022, 2023 and the six months ended June 30, 2024 accounted for 17.2%, 12.3%, 21.5% and 12.3% of our total purchase amount for the respective periods.

Business · 第 259 页

Purchases from our five largest suppliers in each period during the Track Record Period accounted for 46.4%, 38.8%, 55.6% and 45.6% of our total purchases for the respective periods.

Business · 第 259 页

We believe that our operation is not dependent on any particular supplier.

Business · 第 257 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2024-12-18Prospectus
健康之路股份有限公司HealthyWay Inc.02587.HK

前五大供应商采购占比升至42.3%

In 2021, 2022 and 2023 and for the six months ended June 30, 2024, purchases from our five largest suppliers in each of those years in aggregate accounted for 21.9%, 36.7%, 42.3% and 39.6% of our total purchases, respectively, and purchases from our largest supplier in each of those years alone accounted for 9.9%, 19.2%, 18.2% and 11.5% of our total purchases during 2021, 2022 and 2023 and for the six months ended June 30, 2024, respectively.

Business · 第 302 页

We believe we have sufficient alternative suppliers for our business that can provide us with substitutes of comparable quality and prices.

Business · 第 302 页

To the best of our knowledge, all of our five largest suppliers in each year during the Track Record Period are Independent Third Parties.

Business · 第 302 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看

Tell us